Beneficial ownership — 13D / 13G
87,339 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.
Coverage begins December 2024, when the SEC required these schedules to be filed as structured XML.
| Reporting person | Issuer | Schedule | % of class | Event date | Filed |
|---|---|---|---|---|---|
| Wengen Alberta, LP | LAUR Laureate Education, Inc. | 13D/A | 9.83% | Mar 1, 2024 | 2y |
| Common Property Trust | NRC Nrc Health | 13D/A | 16.2% | Mar 1, 2024 | 2y |
| WHITMORE BRADFORD T | SLSN Solesence, Inc. | 13D/A | 71.5% | Mar 1, 2024 | 2y |
| BIOTECHNOLOGY VALUE FUND L P | MLTX MoonLake Immunotherapeutics | 13D/A | 34.6% | Feb 29, 2024 | 2y |
| RIVERNORTH CAPITAL MANAGEMENT, LLC | MMU Western Asset Managed Municipals Fund Inc. | 13G/A | 10.24% | Feb 29, 2024 | 2y |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | RNTX Rein Therapeutics, Inc. | 13G | 6.2% | Feb 28, 2024 | 2y |
| WOLVERINE ASSET MANAGEMENT LLC | ARIZ Arisz Acquisition Corp. Common Stock | 13G/A | 0% | Feb 28, 2024 | 2y |
| Ron Shemer | PKBK Parke Bancorp, Inc. | 13D | 5.17% | Feb 28, 2024 | 2y |
| Samsara BioCapital, L.P. | VTVT vTv Therapeutics Inc. | 13D | 10.4% | Feb 27, 2024 | 2y |
| European Lithium Limited | CRML Critical Metals Corp. | 13D | 83.8% | Feb 27, 2024 | 2y |
| BAKER BROS. ADVISORS LP | VTVT vTv Therapeutics Inc. | 13D | 4.99% | Feb 27, 2024 | 2y |
| KERBER WILLIAM XAVIER III | PDYN Palladyne AI Corp. | 13D | 8.1% | Feb 27, 2024 | 2y |
| MILLENNIUM MANAGEMENT LLC | ALT Altimmune, Inc. | 13G | 5.4% | Feb 26, 2024 | 2y |
| GRIFFIN ASSET MANAGEMENT, INC. | AXDX Accelerate Diagnostics, Inc. | 13G | 8.4% | Dec 31, 2023 | 2y |
| Exor N.V. | CLVT Clarivate PLC | 13D/A | 10.1% | Mar 4, 2024 | 2y |
| Innoviva, Inc. | ARMP Armata Pharmaceuticals, Inc. | 13D/A | 85.3% | Mar 4, 2024 | 2y |
| Karpus Management, Inc. | NEA Nuveen AMT-Free Quality Municipal Income Fund | 13D/A | 8.06% | Mar 4, 2024 | 2y |
| OH Cypress Aggregator, L.P. | CCC CCC Intelligent Solutions Holdings Inc. | 13D/A | 7.4% | Mar 4, 2024 | 2y |
| RS Fund LP | NURO NeuroMetrix, Inc. Common Stock | 13D/A | 9.9% | Mar 4, 2024 | 2y |
| Fund 1 Investments, LLC | TLYS Tilly's, Inc. | 13D/A | 32.39% | Mar 1, 2024 | 2y |
| Karpus Management, Inc. | NRK Nuveen New York Amt-Free Quality Municipal Income Fund | 13D/A | 23% | Mar 1, 2024 | 2y |
| Jacobsen Per A. | BLIN Bridgeline Digital, Inc. | 13G/A | 7.1% | Mar 1, 2024 | 2y |
| 180 Degree Capital Corp. | SCOR Comscore, Inc. | 13D/A | 7.2% | Mar 1, 2024 | 2y |
| New York Life Investment Management LLC | BBAG J.P. Morgan Exchange-Traded Fund Trust | 13G/A | 21.91% | Feb 29, 2024 | 2y |
| Brookstone Capital Management | AAPR Innovator ETFs Trust | 13G/A | 7.62% | Feb 29, 2024 | 2y |
| Lior Susan | OWLT Owlet, Inc. | 13D/A | 48.9% | Feb 29, 2024 | 2y |
| Jay Lichter, Ph.D. (Lichter) | JANX Janux Therapeutics, Inc. | 13D/A | 17.1% | Feb 29, 2024 | 2y |
| Brookstone Capital Management | AAPR Innovator ETFs Trust | 13G/A | 3.35% | Feb 29, 2024 | 2y |
| Intercontinental Exchange, Inc. | BKKT Bakkt, Inc. | 13D/A | 56.6% | Feb 29, 2024 | 2y |
| Brookstone Capital Management | AAPR Innovator ETFs Trust | 13G/A | 7.44% | Feb 29, 2024 | 2y |
| JAB BevCo B.V. | KDP Keurig Dr Pepper Inc. | 13D/A | 27.6% | Feb 29, 2024 | 2y |
| Mithaq Capital SPC | PLCE Childrens Place, Inc. | 13D/A | 56.1% | Feb 29, 2024 | 2y |
| Divisadero Street Capital Management, LP | LPSN Liveperson Inc | 13G | 6.2% | Feb 29, 2024 | 2y |
| Brookstone Capital Management | AAPR Innovator ETFs Trust | 13G/A | 16.45% | Feb 29, 2024 | 2y |
| Brookstone Capital Management | AAPR Innovator ETFs Trust | 13G/A | 5.98% | Feb 29, 2024 | 2y |
| New York Life Investment Management LLC | BAB Invesco Exchange-Traded Fund Trust II | 13G/A | 0% | Feb 29, 2024 | 2y |
| TPG GP A, LLC | TPG TPG Inc. | 13D/A | 74.8% | Feb 29, 2024 | 2y |
| DGP Co., Ltd. | XCUR Exicure, Inc. | 13D/A | 35.4% | Feb 29, 2024 | 2y |
| Divisadero Street Capital Management, LP | ZIMV ZimVie Inc. Common Stock | 13G | 6% | Feb 28, 2024 | 2y |
| STONEHILL CAPITAL MANAGEMENT LLC | MDRX Veradigm Inc. Common Stock | 13G | 19.5% | Feb 28, 2024 | 2y |
| Chicago Capital, LLC | KRNT Kornit Digital Ltd. | 13G | 5.17% | Feb 28, 2024 | 2y |
| Focused Compounding Fund, LP | PRKA Parks America, Inc | 13D/A | 38.44% | Feb 28, 2024 | 2y |
| MILLENNIUM MANAGEMENT LLC | AHR American Healthcare REIT, Inc. | 13G | 5.3% | Feb 23, 2024 | 2y |
| GLAZER CAPITAL, LLC | TGH Textainer Group Holdings limited | 13G | 6.34% | Feb 23, 2024 | 2y |
| Venrock Healthcare Capital Partners III, L.P. | IPSC Century Therapeutics, Inc. | 13G | 5.4% | Feb 21, 2024 | 2y |
| D. E. Shaw & Co., L.P. | AAP Advance Auto Parts Inc | 13G/A | 6.4% | Feb 21, 2024 | 2y |
| Boswell Prayer Ltd | PTHS Pelthos Therapeutics Inc. | 13G | 8.2% | Feb 21, 2024 | 2y |
| Manmohan Patel | TVGN Tevogen Inc. | 13G | 5.6% | Feb 14, 2024 | 2y |
| The Raine Group LLC | BODI Beachbody Company, Inc. | 13D/A | 18.4% | Jan 24, 2024 | 2y |
| Gary M. Katz | SQFT Presidio Property Trust, Inc. | 13D | 5.8% | Jan 5, 2024 | 2y |